Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Cardiovascular risks of hydrox...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Society

Bibliographic Details
Main Authors: Aditya Kapoor, Ulhas Pandurangi, Vanita Arora, Anoop Gupta, Aparna Jaswal, Ashish Nabar, Ajay Naik, Nitish Naik, Narayanan Namboodiri, Amit Vora, Rakesh Yadav, Anil Saxena
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Indian Pacing and Electrophysiology Journal
Subjects:
Hydroxychloroquine
COVID-19
QTc interval
Torsade de pointes
Heart disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0972629220300383
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S0972629220300383

Similar Items

  • Reply to letters regarding our paper “Cardiovascular risks of hydroxychloroquine in treatment and prophylaxis of COVID-19 patients: A scientific statement from the Indian Heart Rhythm Societyˮ
    by: Aditya Kapoor, et al.
    Published: (2020-09-01)
  • Which QTc correction formulae (Bazett, Framingham, or Fridericia) to use for Hydroxychloroquine induced QTc prolongation?
    by: Anunay Gupta, et al.
    Published: (2020-09-01)
  • QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
    by: Sarah Grewal, et al.
    Published: (2020-09-01)
  • QTc interval of healthcare workers from India: Baseline and effect of hydroxychloroquine prophylaxis during the COVID-19 pandemic
    by: Shreyas Gutte, et al.
    Published: (2023-01-01)
  • Hydroxychloroquine and QTc: beyond COVID-19
    by: Alberto Castagna, et al.
    Published: (2020-10-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs